FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

Similar documents
Radiation Oncology Study Guide

ACR TXIT TM EXAM OUTLINE

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

Pancreat ic Cancer UK. policy briefing. A cancer of unmet need: the pancreatic cancer research challenge

DEPARTMENT OF ONCOLOGY ELECTIVE

ANNUAL CANCER REGISTRY REPORT-2005

SUPPLEMENTARY INFORMATION

NCCN National Comprehensive Cancer Network Directory Information

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%

STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL

incidence rate x 100,000/year

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

Supplemental Table 1.1: Prostate cancer prognostic tools

Oncology 101. Cancer Basics

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Cleveland Clinic Laboratories. Anatomic Pathology

Oncology Clinical Program Update. William Sause Medical Director Oncology Clinical Program

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Outcomes Report: Accountability Measures and Quality Improvements

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)

Session 4 Rebecca Poulos

Managing Older Patients With Lymphoma and Multiple Myeloma

Diagnostic IHC in lung and pleura pathology

Epidemiology in Texas 2006 Annual Report. Cancer

Cancer Association of South Africa (CANSA)

Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives

Macmillan Publications

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

American Society of Clinical Oncology PATIENT EDUCATION MATERIALS CATALOG.

Session 4 Rebecca Poulos

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

CLIC Sargent Eligibility Criteria

Applicant Information.

Module Guide 2017/18

S2 File. Clinical Classifications Software (CCS). The CCS is a

SKCC Protocol Review Committee New Study Application

Handbook of Evidence-Based Radiation Oncology 2nd Edition

List of Available TMAs in the PRN

AMERICAN JOINT COMMITTEE ON CANCER AJCC CANCER STAGING

Re-Screening Medical History Questionnaire

PGY-2 ONCOLOGY RESIDENCY ROTATION DESCRIPTION

HUNT CANCER INSTITUTE CANCER SERVICES REPORT 2014

Contents. 3 Pneumology Introduction Positron Emission Tomography: Past and Present 1. 2 Fundamentals. xxx

Cancer A Superficial Introduction

Cancer prevalence. Chapter 7

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

*

Clinical indications for positron emission tomography

UC Brain Tumor Center Molecular Therapeutics Pilot Grant Program 2013/2014

VA Hematology/Oncology Elective

Cancer Awareness Talk ICPAK 2014

Cancer Prevention & Control in Adolescent & Young Adult Survivors

Definition of focal areas

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013

Information Services Division NHS National Services Scotland

Consultant Directory

Competent Pain Management for Older Patients With Cancer

Supplementary Online Content

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

Development status of OPDIVO (nivolumab) 1

New Surgical Oncology Clinic at Nationwide Children s Hospital

Carcinoma of Unknown Primary (CUP)

Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation

Neoplasms/Lymphoma/Leukemia

Outcomes Report: Accountability Measures and Quality Improvements

Current Status and Future Medical Perspectives at MedAustron. U. Mock EBG MedAustron GmbH

TUMOR M ARKERS MARKERS

Oncology Centre Research Unit TUMOR REGISTRY

Cancer survival in Hong Kong SAR, China,

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

Tumor Markers & Cytopathology

Information Services Division NHS National Services Scotland

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Chapter 15: Non-Head and Neck Solid Tumors in Patients with Fanconi Anemia

Cancer in Estonia 2014

Washington, DC Washington, DC Washington, DC Washington, DC 20510

Clinical Summary Note. Digital photographs. Echo Cardiogram. Mammogram. Angiogram. BMD scan Pet scan. Xray US

Corporate Medical Policy

Table of Contents. Preface xi. Acknowledgments xiii. Part I Overview of the Diagnostic Process 1. 1 Overview of Grading and Staging 3

dedicated to curing cancer today. cancercarewny.com

Cancer of Unknown Primary (CUP) Protocol

Corporate Medical Policy

Cancer survival in Busan, Republic of Korea,

Development status of OPDIVO (nivolumab) 1

2016 Cancer Registry Annual Report

Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute

APPENDIX ONE: ICD CODES

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

USMLE STEP 2 CK REVIEW STUDY GUIDE

Information Services Division NHS National Services Scotland

List of Qualifying Conditions

Categories of Cancer. Categorized based on cellular typology

HEMATOLOGY AND ONCOLOGY

Transcription:

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077, pdeinin@tulane.edu https://medicine.tulane.edu/departments/centers-institutes/tulane-cancer-center or www.canceriscurable.com Name: Social Security Number: Academic Rank: Academic Department and Section: Other positions and titles: Office Mailing Address: Campus Mailbox: Office Location (Building & room number): Lab or Clinic Location (Building & room number): Phone: Fax: Pager: Cell: Home Address: Home Phone: E-mail: Webpage:

Major Research Interests: Major Teaching Responsibilities: Major Clinical Responsibilities

Please provide a brief PROSE BIOGRAPHICAL NARRATIVE in the space below, or include as an attachment. This will be a brief paragraph in complete sentences, describing matriculation and professional interests, as opposed to an NIH-style bio-sketch in list format. Please list four to ten selections of your most relevant recent cancer-related PUBLICATIONS, or include as an attachment. Please let us know which cancer-related publications you consider most representative of your work.

RESEARCH SUPPORT Please indicate status of support, i.e., Active, Pending or Planned. If you need more forms, please copy this page. Name of Research Program: Source and Identifying Number: Principle Investigator: Your role on project: % effort: Dates and costs of entire project: Dates and cost for current year: Specific aims of project: Name of Research Program: Source and Identifying Number: Principle Investigator: Your role on project: % effort: Dates and costs of entire project: Dates and cost for current year: Specific aims of project:

SIGNATURES: Applicant: Date: Department Chair: Date: Director, Tulane Cancer Center: Date: ATTACHMENTS: Please attach a current Curriculum Vitae and a photograph, or e-mail a digital photograph to mcross@tulane.edu.

RESEARCH PROGRAMS: Molecular Genetics & Viral Oncogenesis Cell Signaling Epidemiology, Prevention and Control Immunology Clinical Research & Research Training MEMBERSHIP CATEGORY DEFINITIONS: Program Member: Has highest priority for participating in Center-based applications for grants and contracts and for utilization of the Center's resources. 1 University faculty member with at least one active research program fitting the program objectives of the Center. 2 Principal investigator of at least one research program extramurally funded by agencies recognized by the National Cancer Institute. 3 Active participant in research, education and/or administration of the Center and a leader in promoting its development. Contributing Member: Has priority for participating in Center-based applications for grants and contracts and for utilization of its resources. 1 University faculty member with at least one active research program fitting the program objectives of the Center. 2 Active participant in research, education and/or administration of the Center and a leader in promoting its development. Associate Member: Has access to the resources of the Center as well as the opportunity to participate in Center-based applications for grants and contracts. 1 University faculty member, member of another educational and/or research institution or organization, or an individual who is interested in at least one of the programs of the Center. 2 Regular participant in at least one of the functions of the Center.

Clinical faculty members please indicate your areas of specialty. Specialty Please put an X next to your areas of specialty. Please select ALL that apply. Adrenal Gland Tumors Anal Cancer Apheresis Basal Cell Carcinoma Bladder Cancer Bone Marrow Transplant Bone Tumors Brachytherapy Brain/Central Nervous System Tumors Adult Brain/Central Nervous System Tumors Pediatric Breast Cancer Carcinoid Tumors Carotid Body Tumors Cervical Cancer Chemotherapies Clinical Trials Colorectal Cancer Cutaneous Lymphoma Dermatologic Cancers Desmoid Tumors Endocrine Tumors Endometrial Cancer Esophageal Cancer Ewing's Sarcoma Gall Bladder and Bile Duct Tumors Gastric Cancer Gastrointestinal Cancers Genitourinary Cancers Germ Cell Tumors Glioblastoma Gynecologic Cancers Head & Neck Cancers Hematologic Disorders Benign & Premalignant Hematologic Malignancies Hodgkin's Disease Islet Cell Tumors Kaposi's Sarcoma Kidney Cancer Leukemias Adult

Leukemias Pediatric Liver Cancer Lung Cancer Lymphomas Mammography Melanoma Meningioma Merkel Cell Tumors Mesothelioma Moh's Micrographic Surgery Multiple Myeloma Nasal Cavity Cancer Neuroblastoma Neuroendocrine Tumors Neuro Oncology Neurosurgery Ophthalmic Tumors Oral Cavity Cancer Ovarian Cancer Pancreatic Cancer Pain Management Paranasal Sinus Cancer Pediatric Cancers Prostate Cancer Psychoncology Radiation Oncology Rectal Cancer Renal Cancer Retinoblastoma Rhabdomyosarcoma Salivary Gland Tumors Sarcomas Adult Sarcomas Pediatric Sentinel Node Mapping Sinus Cancers Skin Cancers Spinal Cord Tumors Squamous Cell Carcinoma Stem Cell Transplant Stereotactic Radiosurgery Surgical Oncology Testicular Cancer

Thymoma Thyroid Tumors Urologic Cancers Wilms' Tumors